stockrow
Friday 6 November 2026
Export PHVS’s income statement to Excel — free account
Pharvaris N.V.
PHVS Healthcare Biotechnology
- EPS
- +13.8%
- Free cash flow
- −17.3%
- Total debt
- +4.31%
Quarter to June 2026, against a year earlier
34.51
1.98
+6.09%
Follow PHVS
Alert me
Pharvaris N.V. (PHVS) Current ratio
Pharvaris N.V.'s current ratio at the end of the quarter to 30 June 2026 was 11.9×, up 1.8× from fiscal 2025 (10.1×). Over the past ten years it has ranged from 9.2× (fiscal 2022) to 30.3× (fiscal 2021); the current reading is higher than 25% of that period. That is above the Biotechnology industry median of 4.9× and above the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 10.1× | (19.78%) |
| FY2024 | 12.6× | (53.76%) |
| FY2023 | 27.2× | 197.60% |
| FY2022 | 9.2× | (69.79%) |
| FY2021 | 30.3× | 59.37% |
| FY2020 | 19.0× | 77.75% |
| FY2019 | 10.7× | (5.25%) |
| FY2018 | 11.3× | — |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Jun 2026 | 11.9× | 6.22% |
| Mar 2026 | 11.2× | 11.24% |
| Dec 2025 | 10.1× | (21.43%) |
| Sep 2025 | 12.9× | 54.48% |
| 20 more quarters | Free account |
Against its own ten years
Low 9.2×
High 30.3×
Ten-year median
11.9×
Current reading's percentile
25
Current ratio against peers
| Company | Current ratio |
|---|---|
| PVLA Palvella Therapeutics, Inc. compare | 21.2× |
| IMNM Immunome, Inc. compare | 15.1× |
| PHVS Pharvaris N.V. | 11.9× |
| CLDX Celldex Therapeutics, Inc. compare | 11.8× |
| NAMS NewAmsterdam Pharma Company N.V. compare | 11.8× |
| ADMA ADMA Biologics Inc compare | 6.0× |
| VCEL Vericel Corporation compare | 5.1× |
| RXRX Recursion Pharmaceuticals, Inc. compare | 5.0× |
| BHVN Biohaven Ltd. compare | 3.1× |
| Biotechnology industry median | 4.9× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)